SecBot SecBot

USGOW

U.S. GoldMining Inc.
Nasdaq· Gold and Silver Ores· Inc. NV· CIK 0001947244 Materials & Mining
Former ticker of U.S. GoldMining Inc. · USGO stock page →
No price
Market cap
$63.9M
Micro cap
1 year
−56.5%
from $11.66 · Oct 28
30 days
−26.7%
from $6.92
52-week range
$4.55–15.83
−68% from high · low Oct 23
Avg volume 20D
133.6K
shares / day
Short interest
7.2K
−58.9%
Days to cover
1.0
at average volume
New fund stakes
0
Q1 2026 13F · 0 exits
Filing reports
2
analyzed by SecBot
SecBot read BEARISH 2 reports · latest
Balance 1 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 2/2
Strongest BEARISH Nasdaq filed a Form 25-NSE to delist and deregister U.S. GoldMining Inc.'s warrants (exercisable at $13.00…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InstitutionsMIXED

    Q1 2026: 0 added (0 new), 1 trimmed or exited.

  • Short sellersCOVERING

    Short interest −58.9% to 7.2K shares. 1.0 days to cover.

  • TrendDOWNTREND

    31% below its 50-day average. New closing low $4.55 on Oct 23.

Who's buying

13F· Q1 2026
0
new positions
0
exits
FundMoveSharesValue
Clear Street Group Inc.TRIM12,113$5.5K
UBS Group AGTRIM335$563.00
UBS Group AGDOUBLED646$588.00
UBS Group AGNEAR_EXIT252$302.00
Marex Group plcTRIM40,938$74.1K

Quarterly 13F filings are due 45 days after each quarter ends.

Washington

Corporate Lobbying

5 lobbying filings and 0 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current QNoneNoneNo data$0.00
Next QNoneNoneNo data$0.00
Current FYNoneNoneNo data$0.00
Next FYNoneNoneNo data$0.00
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Apr 29, 2026
FDA
Duavee
WARNING: ENDOMETRIAL CANCER, CARDIOVASCULAR DISORDERS, AND PROBABLE DEMENTIA • Women taking DUAVEE should not take additional estrogens [see Warnings

Short side

FINRA· May 15, 2026
7,231
shares short
-58.9%
vs prior settlement
1.0
days to cover
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
May 22, 2026 SEC
Nasdaq filed a Form 25-NSE to delist and deregister U.S. GoldMining Inc.'s warrants (exercisable at $13.00 per share)…
25-NSE · Impact 8/10
Apr 29, 2026 Event
Duavee
WARNING: ENDOMETRIAL CANCER, CARDIOVASCULAR DISORDERS, AND PROBABLE DEMENTIA • Women taking DUAVEE s
Apr 23, 2026 SEC
U.S. GoldMining Inc. extended the expiration date of its public warrants (USGOW) from April 24, 2026, to May 1, 2026…
8-K · Impact 3/10
Mar 31, 2026 Inst.
Clear Street Group Inc. · TRIM
12,113 shares ($5.5K)
Sep 30, 2025 Inst.
UBS Group AG · TRIM
335 shares ($563.00)

SecBot reports

2 filings · 0 bullish · 1 bearish · 1 neutral
All USGOW filing & press-release reports (2)